The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
The role of phosphatidylcholine and choline metabolites to cell proliferation and survival
Abstract
The reorganization of metabolic pathways in cancer facilitates the flux of carbon and reducing equivalents into anabolic pathways at the expense of oxidative phosphorylation. This provides rapidly dividing cells with the necessary precursors for membrane, protein and nucleic acid synthesis. A fundamental metabolic perturbation in cancer is the enhanced synthesis of fatty acids by channeling glucose and/or glutamine into cytosolic acetyl-CoA and upregulation of key biosynthetic genes. This lipogenic phenotype also extends to the production of complex lipids involved in membrane synthesis and lipid-based signaling. Cancer cells display sensitivity to ablation of fatty acid synthesis possibly as a result of diminished capacity to synthesize complex lipids involved in signaling or growth pathways. Evidence has accrued that phosphatidylcholine, the major phospholipid component of eukaryotic membranes, as well as choline metabolites derived from its synthesis and catabolism, contribute to both proliferative growth and programmed cell death. This review will detail our current understanding of how coordinated changes in substrate availability, gene expression and enzyme activity lead to altered phosphatidylcholine synthesis in cancer, and how these changes contribute directly or indirectly to malignant growth. Conversely, apoptosis targets key steps in phosphatidylcholine synthesis and degradation that are linked to disruption of cell cycle regulation, reinforcing the central role that phosphatidylcholine and its metabolites in determining cell fate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–228 of 228
Expression of Phosphatidylethanolamine N-Methyltransferase in Human Hepatocellular Carcinomas
Tessitore, L., Marengo, B., Vance, D. E., Papotti, M. G., Mussa, A., Daidone, M. G., & Costa, A. (2003) · Oncology · doi:10.1159/000072341 · Cited by 45
Lim, P. E., Cornell, R. B., & Vance, D. E. (1986) · Biochemistry and Cell Biology · doi:10.1139/o86-095 · Cited by 45
Stereospecific chemoattraction of lymphoblastic cells by gradients of lysophosphatidylcholine.
Hoffman, R. D., Kligerman, M., Sundt, T. M., Anderson, N. D., & Shin, H. S. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.10.3285 · Cited by 44
Pagel, J. M., Laugen, C., Bonham, L., Hackman, R. C., Hockenbery, D. M., Bhatt, R., Hollenback, D., Carew, H., Singer, J. W., & Press, O. W. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2352 · Cited by 43
Balance of human choline kinase isoforms is critical for cell cycle regulation
Gruber, J., Too, W. C. S., Wong, M. T., Lavie, A., McSorley, T., & Konrad, M. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08573.x · Cited by 42
Lagace, T. A., Storey, M. K., & Ridgway, N. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14367 · Cited by 41
Self-citationTaneva, S. G., Lee, J., & Cornell, R. B. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.01.006 · Cited by 39
Kopp, F. B., Komatsu, T., Nomura, D. K., Trauger, S. A., Thomas, J. R., Siuzdak, G. E., Simon, G. M., & Cravatt, B. F. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.06.009 · Cited by 39
Dennis, M. K., Taneva, S. G., & Cornell, R. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.201715 · Cited by 37
Ridgway, N. D., & Lagace, T. A. (2003) · Biochemical Journal · doi:10.1042/bj20030252 · Cited by 36
Self-citationDeLong, C. J., Hicks, A. M., & Cui, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108911200 · Cited by 36
Taneva, S. G., Dennis, M. K., Ding, Z., Smith, J. L., & Cornell, R. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802595200 · Cited by 34
Diminished expression of phosphatidylethanolamine N-methyltransferase 2 during hepatocarcinogenesis
Tessitore, L., Dianzani, I., Zheng, C. U. I., & Vance, D. E. (1998) · Biochemical Journal · doi:10.1042/bj3370023 · Cited by 30
Sun, B., Zhang, X., Talathi, S., & Cummings, B. S. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138958 · Cited by 30
Ng, M. N. P., Kitos, T. E., & Cornell, R. B. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.09.001 · Cited by 28
Gehrig, K., Morton, C. C., & Ridgway, N. D. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800632-jlr200 · Cited by 28
Self-citationWu, G., Sher, R. B., Cox, G. A., & Vance, D. E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.12.003 · Cited by 26
Momchilova, A., Markovska, T. T., & Pankov, R. G. (1999) · Cell Biology International · doi:10.1006/cbir.1999.0430 · Cited by 26
Sugimoto, H., Okamura, K., Sugimoto, S., Satou, M., Hattori, T., Vance, D. E., & Izumi, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503578200 · Cited by 25
14‐3‐3ζ escorts CCTα for calcium‐activated nuclear import in lung epithelia
Agassandian, M., Chen, B. B., Schuster, C. C., Houtman, J. C. D., & Mallampalli, R. K. (2009) · The FASEB Journal · doi:10.1096/fj.09-136044 · Cited by 22
Geilen, C. C., Wieder, T., Boremski, S., et al. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00221-9 · Cited by 19
Akech, J., Roy, S. S., & Das, S. K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.071 · Cited by 17
van der Sanden, M. H. M., Houweling, M., Duijsings, D., et al. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2003.08.008 · Cited by 17
Serum Autotaxin is not a Useful Biomarker for Ovarian Cancer
Nakamura, K., Igarashi, K., Ohkawa, R., Yokota, H., Masuda, A., Nakagawa, S., Yano, T., Ikeda, H., Aoki, J., & Yatomi, Y. (2012) · Lipids · doi:10.1007/s11745-012-3691-0 · Cited by 15
Agassandian, M., Chen, B. B., Pulijala, R., Kaercher, L., Glasser, J. R., & Mallampalli, R. K. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-10-0863 · Cited by 10
c-Jun N-terminal kinase regulates CTP:phosphocholine cytidylyltransferase
Ryan, A. J., Andrews, M., Zhou, J., et al. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.01.007 · Cited by 9
Testis Development, Fertility, and Survival in Ethanolamine Kinase 2-Deficient Mice
Gustin, S. E., Western, P. S., McClive, P. J., Harley, V. R., Koopman, P. A., & Sinclair, A. H. (2008) · Endocrinology · doi:10.1210/en.2008-0584 · Cited by 9
Caraceni (1998) · doi:10.1002/(sici)1097-0142(19980801)83:3
Cited by
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
Gorden, D. L., Myers, D. S., Ivanova, P. T., Fahy, E., Maurya, M. R., Gupta, S., Min, J., Spann, N. J., McDonald, J. G., Kelly, S. L., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p056002 · Cited by 372
APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia
Sienski, G., Narayan, P., Bonner, J. M., Kory, N., Boland, S., Arczewska, A. A., Ralvenius, W. T., Akay, L., Lockshin, E., He, L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz4564 · Cited by 336
Ilhan, Z. E., Łaniewski, P., Thomas, N., Roe, D. J., Chase, D. M., & Herbst-Kralovetz, M. M. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.04.028 · Cited by 299
Ramamonjisoa, N., & Ackerstaff, E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00003 · Cited by 93
Metadata
- Authors
- Ridgway, N. D.
- Venue
- Critical Reviews in Biochemistry and Molecular Biology
- Publisher
- Informa UK Limited
- Published
- 2013-01-25
- Volume
- 48
- Issue
- 1
- Pages
- 20-38
- ISSN
- 0045-6411 (ISSN-L)
- 1040-9238
- 1549-7798
- OpenAlex
- W2042623389
- Cited by
- 339
- References
- 228
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.